Canadian study of health and aging: study methods and prevalence of dementia
To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. Representative sample of people aged 65 and over int...
Saved in:
Published in | Canadian Medical Association journal (CMAJ) Vol. 150; no. 6; pp. 899 - 913 |
---|---|
Format | Journal Article |
Language | English |
Published |
Canada
CMA Impact, Inc
15.03.1994
|
Subjects | |
Online Access | Get full text |
ISSN | 0820-3946 1488-2329 |
Cover
Abstract | To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.
Prevalence survey.
Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units.
Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region.
Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria.
Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population.
The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021.
These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population. |
---|---|
AbstractList | To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.
Prevalence survey.
Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units.
Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region.
Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria.
Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population.
The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021.
These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population. To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.OBJECTIVETo estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.Prevalence survey.DESIGNPrevalence survey.Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units.SETTINGCommunity and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units.Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region.PARTICIPANTSRepresentative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region.Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria.INTERVENTIONSScreening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria.Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population.MAIN OUTCOME MEASURESPrevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population.The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021.RESULTSThe prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021.These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population.CONCLUSIONSThese Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population. OBJECTIVE: To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. DESIGN: Prevalence survey. SETTING: Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. PARTICIPANTS: Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region. INTERVENTIONS: Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria. MAIN OUTCOME MEASURES: Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population. RESULTS: The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021. CONCLUSIONS: These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population. To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional settings in Canada, excluding those in the two territories, Indian reserves and military units. Representative sample of people aged 65 and over interviewed between February 1991 and May 1992. Those in the community (9008 subjects) were chosen randomly from medicare lists in nine provinces or from the Enumeration Composite Record in Ontario. People in institutions (1255) were randomly selected from residents in stratified random samples of institutions in each region. Screening with the Modified Mini-Mental State (3MS) Examination to identify cognitive impairment. Clinical examination of all those in institutions, those in the community with a 3MS score of less than 78 and a sample of those in the community with a 3MS score of 78 or more to diagnose dementia. Dementia and Alzheimer's disease were defined according to established criteria. Prevalence of dementia of all types, by region, sex and age group, the estimated number of cases in the population by type of dementia and the age-standardized rate per 1000 population. The prevalence estimates suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia (95% confidence interval [CI] 236,800 to 268,400). These were divided roughly equally between the community and institutional samples; the female:male ratio was 2:1. The age-standardized rate ranged from 2.4%, among those aged 65 to 74 years, to 34.5%, among those aged 85 and over. The corresponding figures for Alzheimer's disease were 5.1% overall (161,000 cases; 95% CI 148,100 to 173,900), ranging from 1.0% to 26.0%; for vascular dementia it was 1.5% overall, ranging from 0.6% to 4.8%. If the prevalence estimates remain constant, the number of Canadians with dementia will rise to 592,000 by 2021. These Canadian estimates of the prevalence of dementia fall toward the upper end of the ranges in other studies, whereas the estimates for Alzheimer's disease fall in the middle of the ranges. This may suggest an unusual balance between Alzheimer's and other forms of dementia in the Canadian population. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8131123$$D View this record in MEDLINE/PubMed |
BookMark | eNpdUE1Lw0AQXaRSa_UnCMGDt8DuTLrJehCk-AUFL3peJtlNk5Ls1mxS6L831SLqXObw3rx5752zifPOnrCZSLIsBgQ1YTOeAY9RJfKMnYew4eMgpFM2zQQKAThjqyU5MjW5KPSD2Ue-jCpLTV9F5ExE69qtb49Qa_vKm_AFbDu7o8a6wh4ujG2t62u6YKclNcFeHvecvT8-vC2f49Xr08vyfhVXKFQfmzIvSZLMBfFcWJGngAkpCWg4LyUWRihSSQpKLQQkBlAKAE5JToDKSJyzu2_d7ZC31hTj844ave3qlrq99lTrv4irK732Oz12I9Mx95zdHAU6_zHY0Ou2DoVtGnLWD0GnEpVAFCPx-h9x44fOjeE08CTjC4QD6eq3nR8fx5LxE4QietU |
CODEN | CMAJAX |
ContentType | Journal Article |
Copyright | Copyright Canadian Medical Association Mar 15, 1994 |
Copyright_xml | – notice: Copyright Canadian Medical Association Mar 15, 1994 |
DBID | CGR CUY CVF ECM EIF NPM 4T- 4U- ASE FPQ K6X K9. NAPCQ 7X8 5PM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Docstoc University Readers British Nursing Index British Nursing Index (BNI) (1985 to Present) British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium British Nursing Index University Readers Docstoc MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1488-2329 |
EndPage | 913 |
ExternalDocumentID | PMC1486712 441560681 8131123 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Canada |
GeographicLocations_xml | – name: Canada |
GroupedDBID | --- .55 .XZ 00U 29B 2QL 2WC 354 36B 3O- 4IJ 53G 5GY 5RS 6PF 8F7 AAFWJ AAWTL ABIVO ABOCM ABPMR ACGOD ACIHN ADBBV AEAQA AENEX AFCHL AFCTW AFPKN AHMBA AI. ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EMB EMOBN F5P GROUPED_DOAJ GX1 HYE IAO IEA IHR INH INR IOF L7B M5~ N4W NPM OBH OCB ODZKP OFXIZ OGEVE OHH OVD OVIDX OVT P2P RDH RHI RPM SV3 TEORI U5U UHU VH1 VVN WH7 WOQ X6Y X7M YFH YOC ZGI ZXP ~H1 4T- 4U- ASE FPQ K6X K9. NAPCQ 7X8 5PM |
ID | FETCH-LOGICAL-h319t-dfbfa6a6b1a0b1e1b7234a9623d00f63cd19a9472995124d2361220a4ba239d63 |
ISSN | 0820-3946 |
IngestDate | Thu Aug 21 17:45:29 EDT 2025 Thu Sep 04 21:59:25 EDT 2025 Mon Jun 30 06:10:03 EDT 2025 Tue Aug 05 11:36:17 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-h319t-dfbfa6a6b1a0b1e1b7234a9623d00f63cd19a9472995124d2361220a4ba239d63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-2 content type line 23 |
PMID | 8131123 |
PQID | 204805321 |
PQPubID | 41339 |
PageCount | 15 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1486712 proquest_miscellaneous_76391331 proquest_journals_204805321 pubmed_primary_8131123 |
PublicationCentury | 1900 |
PublicationDate | 1994-03-15 |
PublicationDateYYYYMMDD | 1994-03-15 |
PublicationDate_xml | – month: 03 year: 1994 text: 1994-03-15 day: 15 |
PublicationDecade | 1990 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada – name: Ottawa |
PublicationSubtitle | CMAJ |
PublicationTitle | Canadian Medical Association journal (CMAJ) |
PublicationTitleAlternate | CMAJ |
PublicationYear | 1994 |
Publisher | CMA Impact, Inc |
Publisher_xml | – name: CMA Impact, Inc |
References | 3183318 - J Gerontol. 1988 Nov;43(6):S200-5 2923012 - Acta Psychiatr Scand. 1989 Feb;79(2):190-8 1952826 - Ann Neurol. 1991 Sep;30(3):381-90 2788352 - Acta Psychiatr Scand. 1989 Jun;79(6):557-63 3165596 - Acta Psychiatr Scand Suppl. 1988;338:57-63 2242109 - Psychol Med. 1990 Feb;20(1):183-93 1955260 - Int J Epidemiol. 1991 Sep;20(3):736-48 6610841 - Neurology. 1984 Jul;34(7):939-44 3776750 - Age Ageing. 1986 Sep;15(5):278-84 1615784 - Age Ageing. 1992 May;21(3):205-10 1202204 - J Psychiatr Res. 1975 Nov;12(3):189-98 1387871 - Int J Epidemiol. 1992 Aug;21(4):763-9 2771064 - Neurology. 1989 Sep;39(9):1159-65 3324647 - Acta Psychiatr Scand. 1987 Nov;76(5):465-79 2725870 - Neurology. 1989 Jun;39(6):773-6 1898500 - Am J Public Health. 1991 Jan;81(1):63-8 1853727 - Acta Psychiatr Scand. 1991 May;83(5):350-2 3611032 - J Clin Psychiatry. 1987 Aug;48(8):314-8 1419907 - Cell Growth Differ. 1992 Jul;3(7):443-50 2589085 - Acta Psychiatr Scand. 1989 Oct;80(4):303-9 3494498 - Can J Psychiatry. 1987 Mar;32(2):81-6 2337014 - Age Ageing. 1990 Mar;19(2):84-90 1745347 - Neurology. 1991 Dec;41(12):1911-4 3490741 - Acta Psychiatr Scand. 1986 Aug;74(2):144-51 2810583 - JAMA. 1989 Nov 10;262(18):2551-6 |
References_xml | – reference: 1615784 - Age Ageing. 1992 May;21(3):205-10 – reference: 3183318 - J Gerontol. 1988 Nov;43(6):S200-5 – reference: 2725870 - Neurology. 1989 Jun;39(6):773-6 – reference: 2589085 - Acta Psychiatr Scand. 1989 Oct;80(4):303-9 – reference: 3324647 - Acta Psychiatr Scand. 1987 Nov;76(5):465-79 – reference: 2923012 - Acta Psychiatr Scand. 1989 Feb;79(2):190-8 – reference: 2771064 - Neurology. 1989 Sep;39(9):1159-65 – reference: 2337014 - Age Ageing. 1990 Mar;19(2):84-90 – reference: 1745347 - Neurology. 1991 Dec;41(12):1911-4 – reference: 1387871 - Int J Epidemiol. 1992 Aug;21(4):763-9 – reference: 1955260 - Int J Epidemiol. 1991 Sep;20(3):736-48 – reference: 3165596 - Acta Psychiatr Scand Suppl. 1988;338:57-63 – reference: 2810583 - JAMA. 1989 Nov 10;262(18):2551-6 – reference: 1898500 - Am J Public Health. 1991 Jan;81(1):63-8 – reference: 1419907 - Cell Growth Differ. 1992 Jul;3(7):443-50 – reference: 3776750 - Age Ageing. 1986 Sep;15(5):278-84 – reference: 6610841 - Neurology. 1984 Jul;34(7):939-44 – reference: 2788352 - Acta Psychiatr Scand. 1989 Jun;79(6):557-63 – reference: 3490741 - Acta Psychiatr Scand. 1986 Aug;74(2):144-51 – reference: 1202204 - J Psychiatr Res. 1975 Nov;12(3):189-98 – reference: 1952826 - Ann Neurol. 1991 Sep;30(3):381-90 – reference: 3494498 - Can J Psychiatry. 1987 Mar;32(2):81-6 – reference: 3611032 - J Clin Psychiatry. 1987 Aug;48(8):314-8 – reference: 2242109 - Psychol Med. 1990 Feb;20(1):183-93 – reference: 1853727 - Acta Psychiatr Scand. 1991 May;83(5):350-2 |
SSID | ssj0000327 |
Score | 2.0540574 |
Snippet | To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.
Prevalence survey.
Community and institutional... To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. Prevalence survey. Community and institutional... To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada.OBJECTIVETo estimate the prevalence of dementia and its... OBJECTIVE: To estimate the prevalence of dementia and its subtypes by sex and age group for five regions of Canada. DESIGN: Prevalence survey. SETTING:... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 899 |
SubjectTerms | Age Distribution Aged Aged, 80 and over Aging Canada - epidemiology Caregivers Cost of Illness Databases, Factual Dementia Dementia - classification Dementia - diagnosis Dementia - epidemiology Dementia - prevention & control Female Health aspects Health Services Needs and Demand Health Surveys Humans Logistic Models Male Mass Screening - methods Mental Status Schedule Older people Prevalence Research Design Residence Characteristics Risk Factors Sampling Studies Sex Distribution |
Title | Canadian study of health and aging: study methods and prevalence of dementia |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8131123 https://www.proquest.com/docview/204805321 https://www.proquest.com/docview/76391331 https://pubmed.ncbi.nlm.nih.gov/PMC1486712 |
Volume | 150 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1488-2329 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000327 issn: 0820-3946 databaseCode: DIK dateStart: 19110101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: Open access medical journals (GFMER) customDbUrl: eissn: 1488-2329 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000327 issn: 0820-3946 databaseCode: GX1 dateStart: 19110101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVFQY databaseName: Open access medical journals (GFMER) customDbUrl: eissn: 1488-2329 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000327 issn: 0820-3946 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1488-2329 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0000327 issn: 0820-3946 databaseCode: RPM dateStart: 19850901 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1488-2329 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000327 issn: 0820-3946 databaseCode: RPM dateStart: 19850101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b8IwELYKQ9Wl6guV0keGqluqODYh6YYqKoSALiCxRXbsFJZACyz99T2_AlRIfSxRlEscdJ99OWx_3yF0LynJoNtSHz7fLZ9yImDMYe4L2YxFFpM81LKLg2HUHdPepDnZqPlpdsmKP2afe3kl_0EVrgGuiiX7B2TLRuECnAO-cASE4fgrjEtpgaWThja0RqPA-ma5zMZoSkUvnTAA_Aw9puEZoWcIZ2w7Ty1bdgs5WzCWahNqAXjQ7rnJBGHJdFRtnjLsSRdiFH86sZOALh4aJVgL_HZ0i00to13V6uFr-jLu99NRZzJ6WLz7qqCXWvi21U0qqAIhRbGwJ5u9NwExtXTd6_el9993qW599kcn6Njm617bOP8UHcjiDB0O7I6Ec9R3nvK0m7157hkMPHC0pzF4siaLgDZsEFBPOAQu0PilM3ru-rZChT-F0LXyRc5zFrGIYxZwLDFvhYSyBFJKEQR5RDKBE5ZQ-AMDiWxIhVK6CcOAUc5CkoiI1FC1mBfyEnlJHvE4DwKGZQZNCE5iEUgWS8GZpK24jhrORamFeZkq1WVV2gPX0V1phfigFn1YIefrZQoDMcGEwB014850YWRM0lgpLYWkjlo7fi7tSnh811LMplqAHCuZRhxe_fjSBjradLtrVF19rOUNJHErfqs7xBcMPFF5 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Canadian+study+of+health+and+aging%3A+study+methods+and+prevalence+of+dementia&rft.jtitle=Canadian+Medical+Association+journal+%28CMAJ%29&rft.date=1994-03-15&rft.issn=0820-3946&rft.volume=150&rft.issue=6&rft.spage=899&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0820-3946&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0820-3946&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0820-3946&client=summon |